{"transactions":[{"id":961898,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-19T20:43:50.000Z","date":"2025-12-18","kind":"sale","planned":false,"acquired":false,"shares":461,"price":68.09,"value":31389.49,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $68.00 to $68.35, inclusive. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":8762,"source":{"system":"sec-edgar","filing":"0001437749-25-038426","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000143774925038426/rdgdoc.xml","form_type":"4"}},{"id":961897,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-19T20:43:50.000Z","date":"2025-12-18","kind":"sale","planned":false,"acquired":false,"shares":4660,"price":67.06,"value":312499.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in multiple transactions at prices ranging from $67.00 to $67.28, inclusive. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":9223,"source":{"system":"sec-edgar","filing":"0001437749-25-038426","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000143774925038426/rdgdoc.xml","form_type":"4"}},{"id":964693,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-17T20:41:41.000Z","date":"2025-12-16","kind":"other","planned":false,"acquired":true,"shares":7710,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distribution from Gem Pharmaceuticals, LLC, of which the reporting person is a non-managing member."}],"balance_after":13883,"source":{"system":"sec-edgar","filing":"0001437749-25-038138","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000143774925038138/rdgdoc.xml","form_type":"4"}},{"id":977428,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-12-08T21:49:26.000Z","date":"2025-12-02","kind":"grant","planned":false,"acquired":true,"shares":2924,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest 25% quarterly on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026."}],"balance_after":2924,"derivative":{"exercise_price":75.94,"expiration_date":"2035-12-02","underlying":"Common Stock","underlying_shares":2924},"source":{"system":"sec-edgar","filing":"0001437749-25-037169","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000143774925037169/rdgdoc.xml","form_type":"4"}},{"id":1217086,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-03-08T00:58:06.000Z","date":"2025-03-04","kind":"grant","planned":false,"acquired":true,"shares":11365,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest 25% quarterly on March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025."}],"balance_after":11365,"derivative":{"exercise_price":31.7,"expiration_date":"2035-03-04","underlying":"Common Stock","underlying_shares":11365},"source":{"system":"sec-edgar","filing":"0001437749-25-006726","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000143774925006726/rdgdoc.xml","form_type":"4"}},{"id":1691484,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-01-04T00:38:31.000Z","date":"2023-12-31","kind":"exercise","planned":false,"acquired":false,"shares":2533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2533},"source":{"system":"sec-edgar","filing":"0001437749-24-000484","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000143774924000484/rdgdoc.xml","form_type":"4"}},{"id":1691483,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-01-04T00:38:31.000Z","date":"2023-12-31","kind":"exercise","planned":false,"acquired":true,"shares":2533,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":30863,"source":{"system":"sec-edgar","filing":"0001437749-24-000484","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000143774924000484/rdgdoc.xml","form_type":"4"}},{"id":1766887,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-10-03T23:34:01.000Z","date":"2023-09-30","kind":"exercise","planned":false,"acquired":false,"shares":2533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":2533,"derivative":{"underlying":"Common Stock","underlying_shares":2533},"source":{"system":"sec-edgar","filing":"0001437749-23-027585","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000143774923027585/rdgdoc.xml","form_type":"4"}},{"id":1766886,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-10-03T23:34:01.000Z","date":"2023-09-30","kind":"exercise","planned":false,"acquired":true,"shares":2533,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":28330,"source":{"system":"sec-edgar","filing":"0001437749-23-027585","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000143774923027585/rdgdoc.xml","form_type":"4"}},{"id":1839467,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-07-03T22:49:10.000Z","date":"2023-06-30","kind":"exercise","planned":false,"acquired":false,"shares":2534,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":5066,"derivative":{"underlying":"Common Stock","underlying_shares":2534},"source":{"system":"sec-edgar","filing":"0001437749-23-019260","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000143774923019260/rdgdoc.xml","form_type":"4"}},{"id":1839466,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-07-03T22:49:10.000Z","date":"2023-06-30","kind":"exercise","planned":false,"acquired":true,"shares":2534,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":25797,"source":{"system":"sec-edgar","filing":"0001437749-23-019260","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000143774923019260/rdgdoc.xml","form_type":"4"}},{"id":1927344,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-04-04T21:20:14.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":false,"shares":2533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":7600,"derivative":{"underlying":"Common Stock","underlying_shares":2533},"source":{"system":"sec-edgar","filing":"0001437749-23-009336","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000143774923009336/rdgdoc.xml","form_type":"4"}},{"id":1927343,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-04-04T21:20:14.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":true,"shares":2533,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":23263,"source":{"system":"sec-edgar","filing":"0001437749-23-009336","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000143774923009336/rdgdoc.xml","form_type":"4"}},{"id":2032558,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-02-03T23:47:49.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":10133,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"RSUs vest 25% quarterly on March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"RSUs vest 25% quarterly on March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023."}],"balance_after":10133,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":10133},"source":{"system":"sec-edgar","filing":"0001437749-23-002517","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000143774923002517/rdgdoc.xml","form_type":"4"}},{"id":2032557,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true}}],"security":"Stock Options","published_at":"2023-02-03T23:47:49.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":13930,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest 25% quarterly on March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023."}],"balance_after":13930,"derivative":{"exercise_price":3.16,"expiration_date":"2033-02-01","underlying":"Common Stock","underlying_shares":13930},"source":{"system":"sec-edgar","filing":"0001437749-23-002517","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000143774923002517/rdgdoc.xml","form_type":"4"}},{"id":2072309,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-01-03T21:09:01.000Z","date":"2022-12-31","kind":"exercise","acquired":false,"shares":2859,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 2, 2022, the reporting person was granted 11,436 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 2, 2022, the reporting person was granted 11,436 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2859},"source":{"system":"sec-edgar","filing":"0001437749-23-000171","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000143774923000171/rdgdoc.xml","form_type":"4"}},{"id":2072308,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-01-03T21:09:01.000Z","date":"2022-12-31","kind":"exercise","acquired":true,"shares":2859,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":20730,"source":{"system":"sec-edgar","filing":"0001437749-23-000171","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000143774923000171/rdgdoc.xml","form_type":"4"}},{"id":2147089,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Restricted Stock Units","published_at":"2022-10-03T23:45:13.000Z","date":"2022-09-30","kind":"exercise","acquired":false,"shares":2859,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 2, 2022 the reporting person was granted 11,436 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 2, 2022 the reporting person was granted 11,436 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":2859,"derivative":{"underlying":"Common Stock","underlying_shares":2859},"source":{"system":"sec-edgar","filing":"0001654954-22-013279","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000165495422013279/section16.xml","form_type":"4"}},{"id":2147088,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common Stock","published_at":"2022-10-03T23:45:13.000Z","date":"2022-09-30","kind":"exercise","acquired":true,"shares":2859,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":17871,"source":{"system":"sec-edgar","filing":"0001654954-22-013279","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000165495422013279/section16.xml","form_type":"4"}},{"id":2216897,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Restricted Stock Units","published_at":"2022-07-01T20:19:01.000Z","date":"2022-06-30","kind":"exercise","acquired":false,"shares":2859,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 2, 2022 the reporting person was granted 11,436 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 2, 2022 the reporting person was granted 11,436 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":5718,"derivative":{"underlying":"Common Stock","underlying_shares":2859},"source":{"system":"sec-edgar","filing":"0001654954-22-009151","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000165495422009151/section16.xml","form_type":"4"}},{"id":2216896,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common Stock","published_at":"2022-07-01T20:19:01.000Z","date":"2022-06-30","kind":"exercise","acquired":true,"shares":2859,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":15012,"source":{"system":"sec-edgar","filing":"0001654954-22-009151","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000165495422009151/section16.xml","form_type":"4"}},{"id":2310952,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Restricted Stock Units","published_at":"2022-04-01T21:03:02.000Z","date":"2022-03-31","kind":"exercise","acquired":false,"shares":2859,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 2, 2022 the reporting person was granted 11,436 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 2, 2022 the reporting person was granted 11,436 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":8577,"derivative":{"underlying":"Common Stock","underlying_shares":2859},"source":{"system":"sec-edgar","filing":"0001654954-22-004481","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000165495422004481/section16.xml","form_type":"4"}},{"id":2310951,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common Stock","published_at":"2022-04-01T21:03:02.000Z","date":"2022-03-31","kind":"exercise","acquired":true,"shares":2859,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":12153,"source":{"system":"sec-edgar","filing":"0001654954-22-004481","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000165495422004481/section16.xml","form_type":"4"}},{"id":2411504,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Restricted Stock Units","published_at":"2022-02-05T00:30:54.000Z","date":"2022-02-02","kind":"grant","acquired":true,"shares":11436,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"RSUs vest 25% quarterly on March 31, 2022, June 30, 2022, September 30, 2022 and December 31, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"RSUs vest 25% quarterly on March 31, 2022, June 30, 2022, September 30, 2022 and December 31, 2022."}],"balance_after":11436,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11436},"source":{"system":"sec-edgar","filing":"0001654954-22-001168","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000165495422001168/section16.xml","form_type":"4"}},{"id":2411503,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Stock Options","published_at":"2022-02-05T00:30:54.000Z","date":"2022-02-02","kind":"grant","acquired":true,"shares":15128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest 25% quarterly on March 31, 2022, June 30, 2022, September 30, 2022 and December 31, 2022."}],"balance_after":15128,"derivative":{"exercise_price":2.8,"expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":15128},"source":{"system":"sec-edgar","filing":"0001654954-22-001168","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000165495422001168/section16.xml","form_type":"4"}},{"id":2448081,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Restricted Stock Units","published_at":"2022-01-04T17:59:01.000Z","date":"2021-12-31","kind":"exercise","acquired":false,"shares":751,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":751},"source":{"system":"sec-edgar","filing":"0001654954-22-000114","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000165495422000114/section16.xml","form_type":"4"}},{"id":2448080,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common Stock","published_at":"2022-01-04T17:59:01.000Z","date":"2021-12-31","kind":"exercise","acquired":true,"shares":751,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":9294,"source":{"system":"sec-edgar","filing":"0001654954-22-000114","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000165495422000114/section16.xml","form_type":"4"}},{"id":2554146,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Restricted Stock Units","published_at":"2021-10-01T23:26:08.000Z","date":"2021-09-30","kind":"exercise","acquired":false,"shares":751,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":751,"derivative":{"underlying":"Common Stock","underlying_shares":751},"source":{"system":"sec-edgar","filing":"0001654954-21-010716","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000165495421010716/section16.xml","form_type":"4"}},{"id":2554145,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common Stock","published_at":"2021-10-01T23:26:08.000Z","date":"2021-09-30","kind":"exercise","acquired":true,"shares":751,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":8543,"source":{"system":"sec-edgar","filing":"0001654954-21-010716","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000165495421010716/section16.xml","form_type":"4"}},{"id":2644004,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Restricted Stock Units","published_at":"2021-07-02T21:16:04.000Z","date":"2021-06-30","kind":"exercise","acquired":false,"shares":752,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":1502,"derivative":{"underlying":"Common Stock","underlying_shares":752},"source":{"system":"sec-edgar","filing":"0001654954-21-007599","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000165495421007599/section16.xml","form_type":"4"}},{"id":2644003,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common Stock","published_at":"2021-07-02T21:16:04.000Z","date":"2021-06-30","kind":"exercise","acquired":true,"shares":752,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units"}],"balance_after":7792,"source":{"system":"sec-edgar","filing":"0001654954-21-007599","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000165495421007599/section16.xml","form_type":"4"}},{"id":2763614,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Restricted Stock Units","published_at":"2021-04-01T23:45:32.000Z","date":"2021-03-31","kind":"exercise","acquired":false,"shares":751,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":2254,"derivative":{"underlying":"Common Stock","underlying_shares":751},"source":{"system":"sec-edgar","filing":"0001654954-21-003793","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000165495421003793/section16.xml","form_type":"4"}},{"id":2763613,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common Stock","published_at":"2021-04-01T23:45:32.000Z","date":"2021-03-31","kind":"exercise","acquired":true,"shares":751,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":7040,"source":{"system":"sec-edgar","filing":"0001654954-21-003793","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000165495421003793/section16.xml","form_type":"4"}},{"id":2891960,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Restricted Stock Units","published_at":"2021-01-29T00:02:06.000Z","date":"2021-01-26","kind":"grant","acquired":true,"shares":3005,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"RSUs vest 25% quarterly on March 31, 2021, June 30, 2021, September 30, 2021 and December 31, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"RSUs vest 25% quarterly on March 31, 2021, June 30, 2021, September 30, 2021 and December 31, 2021."}],"balance_after":3005,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3005},"source":{"system":"sec-edgar","filing":"0001654954-21-000923","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000165495421000923/section16.xml","form_type":"4"}},{"id":2891959,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Stock Options","published_at":"2021-01-29T00:02:06.000Z","date":"2021-01-26","kind":"grant","acquired":true,"shares":4443,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest 25% quarterly on March 31, 2021, June 30, 2021, September 30, 2021 and December 31, 2021."}],"balance_after":4443,"derivative":{"exercise_price":6.81,"expiration_date":"2031-01-25","underlying":"Common Stock","underlying_shares":4443},"source":{"system":"sec-edgar","filing":"0001654954-21-000923","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000165495421000923/section16.xml","form_type":"4"}},{"id":2919791,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Restricted Stock Units","published_at":"2021-01-05T22:35:04.000Z","date":"2020-12-31","kind":"exercise","acquired":false,"shares":322,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 31, 2020 the reporting person was granted 1,289 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2020, June 30, 2020, September 30, 2020, and December 31, 2020. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.  Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 31, 2020 the reporting person was granted 1,289 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2020, June 30, 2020, September 30, 2020, and December 31, 2020. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.  Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":322},"source":{"system":"sec-edgar","filing":"0001654954-21-000150","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000165495421000150/section16.xml","form_type":"4"}},{"id":2919790,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Restricted Stock Units","published_at":"2021-01-05T22:35:04.000Z","date":"2020-09-30","kind":"exercise","acquired":false,"shares":322,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 31, 2020 the reporting person was granted 1,289 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2020, June 30, 2020, September 30, 2020, and December 31, 2020. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.  Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 31, 2020 the reporting person was granted 1,289 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2020, June 30, 2020, September 30, 2020, and December 31, 2020. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.  Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":322,"derivative":{"underlying":"Common Stock","underlying_shares":322},"source":{"system":"sec-edgar","filing":"0001654954-21-000150","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000165495421000150/section16.xml","form_type":"4"}},{"id":2919789,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common Stock","published_at":"2021-01-05T22:35:04.000Z","date":"2020-12-31","kind":"exercise","acquired":true,"shares":322,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":6289,"source":{"system":"sec-edgar","filing":"0001654954-21-000150","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000165495421000150/section16.xml","form_type":"4"}},{"id":2919788,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common Stock","published_at":"2021-01-05T22:35:04.000Z","date":"2020-09-30","kind":"exercise","acquired":true,"shares":322,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":5967,"source":{"system":"sec-edgar","filing":"0001654954-21-000150","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000165495421000150/section16.xml","form_type":"4"}},{"id":3091231,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Restricted Stock Units","published_at":"2020-07-02T20:33:55.000Z","date":"2020-06-30","kind":"exercise","acquired":false,"shares":323,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 31, 2020 the reporting person was granted 1,289 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2020, June 30, 2020, September 30, 2020, and December 31, 2020. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.  Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 31, 2020 the reporting person was granted 1,289 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2020, June 30, 2020, September 30, 2020, and December 31, 2020. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.  Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":644,"derivative":{"underlying":"Common Stock","underlying_shares":323},"source":{"system":"sec-edgar","filing":"0001654954-20-007301","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000165495420007301/section16.xml","form_type":"4"}},{"id":3091230,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common Stock","published_at":"2020-07-02T20:33:55.000Z","date":"2020-06-30","kind":"exercise","acquired":true,"shares":323,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":5645,"source":{"system":"sec-edgar","filing":"0001654954-20-007301","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000165495420007301/section16.xml","form_type":"4"}},{"id":3188891,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Restricted Stock Units","published_at":"2020-04-01T18:37:32.000Z","date":"2020-03-31","kind":"exercise","acquired":false,"shares":322,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 31, 2020 the reporting person was granted 1,289 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2020, June 30, 2020, September 30, 2020, and December 31, 2020. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.  Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 31, 2020 the reporting person was granted 1,289 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2020, June 30, 2020, September 30, 2020, and December 31, 2020. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.  Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":967,"derivative":{"underlying":"Common Stock","underlying_shares":322},"source":{"system":"sec-edgar","filing":"0001654954-20-003676","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000165495420003676/section16.xml","form_type":"4"}},{"id":3188890,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common Stock","published_at":"2020-04-01T18:37:32.000Z","date":"2020-03-31","kind":"exercise","acquired":true,"shares":322,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":5322,"source":{"system":"sec-edgar","filing":"0001654954-20-003676","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000165495420003676/section16.xml","form_type":"4"}},{"id":3259078,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Stock Options","published_at":"2020-02-21T01:54:01.000Z","date":"2020-01-31","kind":"grant","acquired":true,"shares":5646,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options vest 25% on March 31, 2020, 25% on June 30, 2020, 25% on September 30, 2020, and 25% on December 31, 2020."}],"balance_after":5646,"derivative":{"exercise_price":14.35,"expiration_date":"2030-01-31","underlying":"Common Stock","underlying_shares":5646},"source":{"system":"sec-edgar","filing":"0001654954-20-001791","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000165495420001791/section16.xml","form_type":"4"}},{"id":3259077,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Restricted Stock Units","published_at":"2020-02-21T01:54:01.000Z","date":"2020-01-31","kind":"grant","acquired":true,"shares":1289,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock units vest 25% on April 1, 2020, 25% on July 1, 2020, 25% on October 1, 2020, and 25% on January 1, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Restricted stock units vest 25% on April 1, 2020, 25% on July 1, 2020, 25% on October 1, 2020, and 25% on January 1, 2021."}],"balance_after":1289,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1289},"source":{"system":"sec-edgar","filing":"0001654954-20-001791","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000165495420001791/section16.xml","form_type":"4"}},{"id":3806482,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":71082,"kind":"person","name":"KLAUSNER ARTHUR J","position":1,"cik":"0001207790","reported_name":"KLAUSNER ARTHUR J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Stock options","published_at":"2018-09-27T22:42:40.000Z","date":"2018-08-09","kind":"grant","acquired":true,"shares":26100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options vest 20% on January 1, 2019, 20% on April 1, 2019, 20% on July 1, 2019, 20% on October 1, 2019 and 20% on January 1, 2020."}],"balance_after":26100,"derivative":{"exercise_price":6,"exercise_date":"2019-01-01","expiration_date":"2028-08-08","underlying":"Common stock","underlying_shares":26100},"source":{"system":"sec-edgar","filing":"0001654954-18-010576","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1207790/000165495418010576/section16.xml","form_type":"4"}}]}